In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

To apply a precision medicine approach to this disease, Character Bio has partnered with over 150 ophthalmology treatment ...

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

The "Dry Age-Related Macular Degeneration - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The "Dry AMD -Epidemiology - 2034" report delivers an in-depth ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related ... characterised by the loss of photoreceptors and retinal pigment epithelial (RPE) cells in the central ...

Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight ... by the loss of photoreceptors and retinal pigment epithelial (RPE ...

Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. A ...

Research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Belite Bio in a research note issued on Tuesday, March 18th. Cantor Fitzgerald analyst J. Kim now ...

One of the most popular pet dog people have are the Labrador Retrievers. These are mid to large sized pets that are known for ...